| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/04/2009 | EP1725229B1 Use of desoxypeganine for the treatment of schizophrenic psychoses |
| 03/04/2009 | EP1708693B1 Pharmaceutical compositions containing paltinum complexes with secondary xanthates and therapeutic uses thereof |
| 03/04/2009 | EP1706405B1 4'-substituted carbovir- and abacavir-derivatives as well as related compounds with hiv and hcv antiviral activity |
| 03/04/2009 | EP1696913B1 Pharmaceutical composition of vinflunine for parenteral administration, preparation method thereof and use of same |
| 03/04/2009 | EP1682185B1 Compositions and methods for treating a posterior segment of an eye |
| 03/04/2009 | EP1670896A4 Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry |
| 03/04/2009 | EP1663236B1 Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and a biphosphonate |
| 03/04/2009 | EP1660443B1 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 03/04/2009 | EP1635816B1 Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases |
| 03/04/2009 | EP1635803B1 Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain |
| 03/04/2009 | EP1635792B1 Stable pharmaceutical compositions of 2-aza-bicyclo¬3.3.0 -octane-3-carboxylic acid derivatives |
| 03/04/2009 | EP1616005B1 Mannosyl(1-2)glycosyl(1-2)glycerate for the stabilisation and preservation of biomaterials |
| 03/04/2009 | EP1601649A4 A1 adenosine receptor antagonists |
| 03/04/2009 | EP1578427B1 Use of gnrh agonists to support the luteal phase during infertility treatment |
| 03/04/2009 | EP1575579B1 Compositions comprising a combination of diphenyl urea impdh inhibitors and apoptosis-inducing anti-cancer agents |
| 03/04/2009 | EP1569630A4 Methods for preventing phototoxic damage during photodynamic therapy |
| 03/04/2009 | EP1551812B1 Mitotic kinesin inhibitors |
| 03/04/2009 | EP1546150B1 Pyrrole derivatives as inhibitors of cyteine proteases |
| 03/04/2009 | EP1539738B1 Novel aryl- 4-halo-4- heteroarylmethylamino)-methyl -piperidin-1-yl -methanone derivatives, methods for production and use thereof as medicaments |
| 03/04/2009 | EP1521572B1 Bioerodible film for ophthalmic drug delivery |
| 03/04/2009 | EP1506951B1 Method for the preparation of total salvianolic acid |
| 03/04/2009 | EP1490071B1 Therapeutic uses of sapogenins |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | EP1472209B1 Lipoxin a4 analogs |
| 03/04/2009 | EP1455785B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 03/04/2009 | EP1454624B1 Antiviral, antibacterial pharmaceutical composition of cantharidic anhydride and method of preparation thereof |
| 03/04/2009 | EP1453507B1 Solubilized topoisomerase poison agents |
| 03/04/2009 | EP1452527B1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
| 03/04/2009 | EP1427720B1 3-substituted-4-pyrimidone derivatives |
| 03/04/2009 | EP1418813A4 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 03/04/2009 | EP1416926A4 Zinc containing compositions for anti-viral use |
| 03/04/2009 | EP1408931B1 Isotonic lipid emulsions |
| 03/04/2009 | EP1392312B1 TRIAZOLO 4,5-d PYRIMIDINE DERIVATIVES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 03/04/2009 | EP1380306B1 Remedies for restless leg syndrome |
| 03/04/2009 | EP1379269B1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 03/04/2009 | EP1379135B1 Formulations comprising entrapped active ingredients and uses thereof |
| 03/04/2009 | EP1294876B1 Eg-vegf nucleic acids and polypeptides and methods of use |
| 03/04/2009 | EP1255845B1 Modified cytokines for use in cancer therapy |
| 03/04/2009 | EP1252322B2 Herpes virus strains for gene therapy |
| 03/04/2009 | EP1246917B1 Human stra6 polypeptides |
| 03/04/2009 | EP1230243B1 Poycyloalkylpurines as adenosine receptor antagonists |
| 03/04/2009 | EP1189581B1 Topical anti-microbial compositions |
| 03/04/2009 | EP1146864B1 Ph independent extended release pharmaceutical formulation |
| 03/04/2009 | EP1140908B1 Triazole compounds with dopamine-d3-receptor affinity |
| 03/04/2009 | EP1123099B1 Novel indenoisoquinolines as antineoplastic agents |
| 03/04/2009 | EP1085804B1 Method and composition for the treatment of epidermal irritations and infections |
| 03/04/2009 | EP0869974B1 Compounds with growth hormone releasing properties |
| 03/04/2009 | CN201200626Y Tablet capsule containing diphosphonates tablet and vitamin D tablet |
| 03/04/2009 | CN201200505Y Intravascular stent for treating coronary heart disease |
| 03/04/2009 | CN101379396A Method for detecting a biomarker of oxidative stress in a biological sample |
| 03/04/2009 | CN101379195A Immunostimulatory activity of palindromic immune modulatory oligonucleotides (IMO tm) contiaining different lengths of palindromic segments |
| 03/04/2009 | CN101379067A Thieno-pyridine derivatives as MEK inhibitors |
| 03/04/2009 | CN101379066A HCV NS5B inhibitors |
| 03/04/2009 | CN101379064A Trihydrochloride forms of a dihydropteridinone derivative and processes for preparation |
| 03/04/2009 | CN101379063A 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/04/2009 | CN101379062A 3,9-diazabicyclo [3.3.1] nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/04/2009 | CN101379061A Inhibitors of E1 activating enzyme |
| 03/04/2009 | CN101379060A Benzazole derivatives, compositions, and methods of use as Aurora kinase inhibitors |
| 03/04/2009 | CN101379059A N-hydroxyacrylamide compounds |
| 03/04/2009 | CN101379058A Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases |
| 03/04/2009 | CN101379057A Succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2- (8-hydroxy-2-oxo-1, 2-dihydroquinolin-5-yl) eth ylaminoimethyl]} -5-methoxyphenylcarbamoyl) ethyl]piperidin-4-yl es |
| 03/04/2009 | CN101379056A Compounds for the inhibition of integrins and use thereof |
| 03/04/2009 | CN101379055A Substituted quinolones III |
| 03/04/2009 | CN101379054A Piperidine derivatives as CXCR3 receptor antagonists |
| 03/04/2009 | CN101379053A New citrate salt of an indole derivative and its pharmaceutical use |
| 03/04/2009 | CN101379049A Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same |
| 03/04/2009 | CN101379048A Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents |
| 03/04/2009 | CN101379046A Processes for taxane derivatives and intermediates useful therein |
| 03/04/2009 | CN101379043A Substituted 2-Aminopyrimidine-4-ones, their pharmaceutical compositions and their use in the treatment and/or prevention of ass-related pathologies |
| 03/04/2009 | CN101379042A Substituted cinnoline derivatives as GABAA-receptor modulators and method for their synthesis |
| 03/04/2009 | CN101379041A Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 03/04/2009 | CN101379040A Muscarinic receptor antagonists |
| 03/04/2009 | CN101379036A Anthranilamide/2-amino-heteroarene carboxamide derivatives |
| 03/04/2009 | CN101379033A Secondary amines |
| 03/04/2009 | CN101379030A Sulfonamide derivatives to treat infection with hepatitis c virus |
| 03/04/2009 | CN101379027A Mutilin derivatives and their use as pharmaceutical |
| 03/04/2009 | CN101379024A Process for manufacturing entacapone |
| 03/04/2009 | CN101378766A Composition for inhibiting adhesion |
| 03/04/2009 | CN101378765A Hydrophobic elastomeric polymer chemistry device for inhibiting the growth of onychomycosis and urushiol-induced allergic contact dermatitis |
| 03/04/2009 | CN101378764A Diagnosis, prognosis and monitoring of disease progression of systemic lupus erythematosus through blood leukocyte microarray analysis |
| 03/04/2009 | CN101378763A Trialkylsilylbenzylaminocarboxyindoles, indazoles and indolines and their use in treating CETP-mediated disorders |
| 03/04/2009 | CN101378762A A method of treating an acute vascular disorder |
| 03/04/2009 | CN101378761A Cationic steroid antimicrobial compositions and methods of use |
| 03/04/2009 | CN101378760A Pharmaceutical compositions comprising methotrexate |
| 03/04/2009 | CN101378759A Lyophilized compositions of a triazolopyrimidine compound |
| 03/04/2009 | CN101378758A Preparation of 7-alkenyl-3 quinolinecarbonitriles via a palladium mediated coupling reaction |
| 03/04/2009 | CN101378757A Thiadiazole derivatives for the treatment of neuro degenerative diseases |
| 03/04/2009 | CN101378756A Piperidine derivatives as CXCR3 receptor antagonists |
| 03/04/2009 | CN101378755A Hydroxylamines and derivatives as anti-angiogenic agents |
| 03/04/2009 | CN101378754A Pharmaceutical use of 2-hydroxy-3- [5- (morpholin-4- ylmethyl) pyridine-2-yl] -1H- indole-5-carbonitrile as a free base or salts |
| 03/04/2009 | CN101378753A Lansoprazole orally disintegrating tablets |
| 03/04/2009 | CN101378752A 4-acylaminopyridine derivative mediated neurogenesis |
| 03/04/2009 | CN101378751A Tuberous sclerosis treatment |
| 03/04/2009 | CN101378750A Indolone compounds useful to treat cognitive impairment |
| 03/04/2009 | CN101378749A High dosage of mycophenolic acid (MPA) |
| 03/04/2009 | CN101378748A Pharmaceutical composition having a ruthenium oxalato compound and method of using the same |
| 03/04/2009 | CN101378747A Whitening dermatological preparations |
| 03/04/2009 | CN101378746A Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| 03/04/2009 | CN101378745A Pharmaceutical composition comprising meglitinide for prevention of hepatic fibrosis |
| 03/04/2009 | CN101378744A Oxadiazole compounds as urokinase inhibitors |